Literature DB >> 24344207

The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia.

Elisabeth G W Huijskens1,2, Marion Koopmans3,4, Fernand M H Palmen2, Adriana J M van Erkel2, Paul G H Mulder5, John W A Rossen6,2.   

Abstract

Current diagnostics for community-acquired pneumonia (CAP) include testing for a wide range of pathogens, which is costly and not always informative. We compared clinical and laboratory parameters of patients with CAP caused by different groups of pathogens to evaluate the potential for targeted diagnostics and directed treatment. In a prospective study, conducted between April 2008 and April 2009, adult patients with CAP were tested for the presence of a broad range of possible respiratory pathogens using bacterial cultures, PCR, urinary antigen testing and serology. Of 408 patients with CAP, pathogens were detected in 263 patients (64.5%). Streptococcus pneumoniae and influenza A virus were the most frequently identified bacterial and viral pathogens, respectively. Age had a significant effect on the prediction of aetiology (P = 0.054), with an increase in the relative contribution of viruses with advancing age. Multivariate analyses further showed that the presence of cough increased the likelihood of detecting a viral pathogen [odds ratio (OR) 5.536, 95% confidence interval (CI) 2.130-14.390], the presence of immunodeficiency decreased the likelihood of detecting a bacterial pathogen (OR 0.595, 95 % CI 0.246-1.437) and an increase in pneumonia severity index score increased the likelihood of detecting a pathogen in general. Although several variables were independently associated with the detection of a pathogen group, substantial overlap meant there were no reliable clinical predictors to distinguish aetiologies. Therefore, testing for common respiratory pathogens is still necessary to optimize treatment.

Entities:  

Mesh:

Year:  2013        PMID: 24344207     DOI: 10.1099/jmm.0.067108-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  33 in total

1.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

Review 2.  Infectious Diseases in Older Adults of Long-Term Care Facilities: Update on Approach to Diagnosis and Management.

Authors:  Robin L P Jump; Christopher J Crnich; Lona Mody; Suzanne F Bradley; Lindsay E Nicolle; Thomas T Yoshikawa
Journal:  J Am Geriatr Soc       Date:  2018-04       Impact factor: 5.562

3.  Comparative Clinical Evaluation of NeoPlex RB-8 with Seeplex PneumoBacter ACE for Simultaneous Detection of Eight Respiratory Bacterial Pathogens.

Authors:  Jeong Woo Kim; Seong Soo Hong; In Seop Lee; Hyun Young Chi; Soo-Ok Kim; Hyeong Nyeon Kim; Sun Pyo Hong
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

4.  Detection of viral and bacterial pathogens in hospitalized children with acute respiratory illnesses, Chongqing, 2009-2013.

Authors:  Lan Wei; Wei Liu; Xiao-Ai Zhang; En-Mei Liu; Yin Wo; Benjamin J Cowling; Wu-Chun Cao
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

5.  The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.

Authors:  Johanna Nagel; Pierre Geborek; Tore Saxne; Göran Jönsson; Martin Englund; Ingemar F Petersson; Jan-Åke Nilsson; Lennart Truedsson; Meliha C Kapetanovic
Journal:  Arthritis Res Ther       Date:  2015-05-19       Impact factor: 5.156

6.  Predictors of viral pneumonia in patients with community-acquired pneumonia.

Authors:  Ji Eun Kim; Uh Jin Kim; Hee Kyung Kim; Soo Kyung Cho; Joon Hwan An; Seung-Ji Kang; Kyung-Hwa Park; Sook-In Jung; Hee-Chang Jang
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

Review 7.  Epidemiology of virus-induced asthma exacerbations: with special reference to the role of human rhinovirus.

Authors:  Takeshi Saraya; Daisuke Kurai; Haruyuki Ishii; Anri Ito; Yoshiko Sasaki; Shoichi Niwa; Naoko Kiyota; Hiroyuki Tsukagoshi; Kunihisa Kozawa; Hajime Goto; Hajime Takizawa
Journal:  Front Microbiol       Date:  2014-05-26       Impact factor: 5.640

8.  Co-infections with respiratory viruses in dogs with bacterial pneumonia.

Authors:  S J Viitanen; A Lappalainen; M M Rajamäki
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

9.  Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection.

Authors:  Robert Sambursky; Nathan Shapiro
Journal:  Eur Clin Respir J       Date:  2015-12-10

10.  Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia.

Authors:  Naomi J Gadsby; Clark D Russell; Martin P McHugh; Harriet Mark; Andrew Conway Morris; Ian F Laurenson; Adam T Hill; Kate E Templeton
Journal:  Clin Infect Dis       Date:  2016-01-07       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.